Kura Oncology KURA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's free cash flow?
- Kura Oncology (KURA) reported free cash flow of -$85.98M in Q1 2026.
- How has Kura Oncology's free cash flow changed year-over-year?
- Kura Oncology's free cash flow decreased by 19.1% year-over-year, from -$72.22M to -$85.98M.
- What is the long-term trend for Kura Oncology's free cash flow?
- Over 3 years (2021 to 2024), Kura Oncology's free cash flow has grown at a 8.2% compound annual growth rate (CAGR), from -$105.7M to $133.85M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.